Company news
Lobe Sciences Ltd news in 2024
Lobe Sciences Ltd's news releases, calls and decks from 2024, newest first.
Lobe Sciences and Alera Pharma Announce Notice of Allowance for Second U.S. Patent for Conjugated Psilocin™
November 18, 2024
Lobe Sciences, Ltd. Announces the Appointment of Enclave Capital and Peak Asset Management to Fund Clinical Trials of Conjugated Psilocin™
October 16, 2024
Lobe Sciences and Alera Pharma Announce Issuance of U.S. Patent for Conjugated Psilocin
October 3, 2024
Lobe Sciences Announces Creation of Wholly Owned Subsidiary, Alera Pharma, Inc.
August 15, 2024
Lobe Sciences Announces Appointment of a New Board of Directors and Executive Management Team
August 12, 2024
Lobe Sciences Announces Update
June 4, 2024
Wesley Ramjeet to Join Lobe Sciences’ Board of Directors, Bringing Decades of Strategic Financial Expertise
June 3, 2024
Lobe Sciences Announces Frederick D. Sancilio Ph.D. to Join Board of Directors
May 31, 2024
Former Merck Director and Vanderbilt Vice-Chancellor, Dr. Harry Jacobson, to Join Lobe Sciences Board of Directors
May 30, 2024
Lobe Sciences Ltd. and Clearway Global Announce Change of Control and Focus on Creating Value for Shareholders
May 21, 2024
Lobe Sciences Provides Company Review of 2023
January 8, 2024